Open | 11.97 |
Previous Close | 12.205 |
Day Range | 11.89 - 12.71 |
52-Week Range | 12.14 - 30.41 |
All-Time High | 150.00 |
Avg. Volume (50-day) | 2,119,569.5 |
EPS (TTM) | -5.15 |
Next Earnings Date | 2025-05-06 (AMC) |
Last Earnings Date | 2025-02-10 |
Forward Annual Dividend (Yield) | - |
Trailing Annual Dividend (Yield) | - |
Options | Yes |
P/E Ratio | -2.37 |
PEG Ratio | -3.24 |
Price to Book | 29.14 |
Price to Cash Flow | - |
Price to Free Cash Flow | - |
Total Sales (TTM) | 2.50 M |
Revenue per Share (TTM) | 0.02 |
Shares Outstanding | 137.317 M |
Share Float (%) | 114.16 M |
% Held by Institutions | 70.71 |
Dividends Per Share (TTM) | - |
Ex-Dividend Date | - |
+/- EMA(20) | 14.81 (-15.73%) |
+/- SMA(50) | 17.69 (-29.45%) |
+/- SMA(200) | 21.26 (-41.30%) |
5-Day Perf. | -10.41% |
1-Month Perf. | -34% |
3-Month Perf. | -36.49% |
6-Month Perf. | -35.07% |
YTD Perf. | -33.62% |
1-Year Perf. | -52.35% |
RSI(14) | 27.9 |
ATR(14) | 0.92 |
ADX(14) | 31.71 |
Beta (5Y) | 1.53 |
As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.
ARWR has triggered the following predefined scans:
P&F Double Bottom Breakdown |
P&F Descending Triple Bottom Breakdown |
Elder Bar Turned Blue |
New 52-week Lows |
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.